Genomics and Molecular Medicine Unit, CSIR-Institute of Genomics and Integrative Biology, Mathura Road, New Delhi, 110025, India.
Academy of Scientific and Innovative Research (AcSIR), CSIR-Institute of Genomics and Integrative Biology, Mathura Road, New Delhi, 110025, India.
Sci Rep. 2017 Sep 14;7(1):11541. doi: 10.1038/s41598-017-11177-1.
We observed extra-telomeric binding of the telomere repeat binding factor TRF2 within the promoter of the cyclin-dependent kinase CDKNIA (p21/CIP1/WAF1). This result in TRF2 induced transcription repression of p21. Interestingly, p21 repression was through engagement of the REST-coREST-LSD1-repressor complex and altered histone marks at the p21 promoter in a TRF2-dependent fashion. Furthermore, mutational analysis shows p21 repression requires interaction of TRF2 with a p21 promoter G-quadruplex. Physiologically, TRF2-mediated p21 repression attenuated drug-induced activation of cellular DNA damage response by evading G2/M arrest in cancer cells. Together these reveal for the first time role of TRF2 in REST- repressor complex mediated transcription repression.
我们观察到端粒重复结合因子 TRF2 在细胞周期蛋白依赖性激酶 CDKNA(p21/CIP1/WAF1)启动子内的端粒外结合。这导致 TRF2 诱导 p21 的转录抑制。有趣的是,p21 的抑制是通过 REST-coREST-LSD1 抑制复合物的参与和以 TRF2 依赖的方式改变 p21 启动子上的组蛋白标记来实现的。此外,突变分析表明 p21 的抑制需要 TRF2 与 p21 启动子 G-四链体的相互作用。从生理上讲,TRF2 介导的 p21 抑制通过逃避癌细胞中的 G2/M 阻滞来减弱药物诱导的细胞 DNA 损伤反应的激活。这些结果首次揭示了 TRF2 在 REST-抑制复合物介导的转录抑制中的作用。